In more than 70% of infant acute lymphoblastic leukemia (infant-ALL) cases, the main driver mutation is a chromosomal translocation that leads to rearrangement of the Mixed Lineage Leukemia (MLL/KMT2A) gene (MLL-r), producing MLL fusion proteins1–4. The gene discussed is KMT2A; the disease is leukemia.